P881: DURABILITY OF RESPONSES WITH BIWEEKLY DOSING OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA ACHIEVING A CLINICAL RESPONSE IN THE MAJESTEC‐1 STUDY
Bhutani, Manisha, Garfall, Alfred, Uttervall, Katarina, Usmani, Saad Z, Karlin, Lionel, Benboubker, Lotfi, Nahi, Hareth, San Miguel, Jesús, Trancucci, Danielle, Qi, Keqin, Stephenson, Tara, Perales‐Puchalt, Alfredo, Chastain, Katherine, Chari, Ajai
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC‐1
Donk, Niels W.C.J., Garfall, Alfred, Benboubker, Lotfi, Uttervall, Katarina, Groen, Kaz, Rosiñol Dachs, Laura, Hodin, Caroline, Stephenson, Tara, Trancucci, Danielle, Perales‐Puchalt, Alfredo, Kobos, Rachel, Banerjee, Arnob, Mateos, Maria‐Victoria
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P879: LONG‐TERM FOLLOW‐UP FROM MAJESTEC‐1 OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Sidana, Surbhi, Moreau, Philippe, Garfall, Alfred, Bhutani, Manisha, Oriol, Albert, Nooka, Ajay, Martin, Tom, Rosiñol Dachs, Laura, Mateos, Maria‐Victoria, Bahlis, Nizar J, Popat, Rakesh, Besemer, Britta, Martinez‐Lopez, Joaquín, Krishnan, Amrita, Delforge, Michel, Trancucci, Danielle, Verona, Raluca, Stephenson, Tara, Chastain, Katherine, Donk, Niels W.C.J.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
Frerichs, Kristine, Verkleij, Christie, Mateos, Maria‐Victoria, Zweegman, Sonja, Groen, Kaz, Kuipers, Ilse, Martin, Tom, Rodriguez, Cesar, Nooka, Ajay, Kruijswijk, Sandy, Skerget, Sheri, Doyle, Margaret, Banerjee, Arnob, Chastain, Katherine, Perales‐Puchalt, Alfredo, Stephenson, Tara, Uhlar, Clarissa, Kobos, Rachel, Verona, Raluca, Donk, Niels W.C.J.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Teclistamab, a B-cell maturation antigenxCD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
Usmani, SZ, Garfall, AL, van, de Donk NWCJ, Nahi, H, San-Miguel, JF, Oriol, A, Rosinol, L, Chari, A, Bhutani, M, Karlin, L
Published in The Lancet (British edition) (21.08.2021)
Published in The Lancet (British edition) (21.08.2021)
Get full text
Journal Article
An Exercise for Teaching the Employment Law Implications of Employee Blogging
Lee, Konrad S., Thue, Matthew I., Oldham, Jared, Stephenson, Tara N.
Published in The Journal of legal studies education (01.08.2009)
Published in The Journal of legal studies education (01.08.2009)
Get full text
Journal Article
Teclistamab in Relapsed or Refractory Multiple Myeloma
Moreau, Philippe, Garfall, Alfred L., van de Donk, Niels W.C.J., Nahi, Hareth, San-Miguel, Jesús F., Oriol, Albert, Nooka, Ajay K., Martin, Thomas, Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Bahlis, Nizar, Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Verona, Raluca, Girgis, Suzette, Lin, Shun X.W., Olyslager, Yunsi, Jaffe, Mindy, Uhlar, Clarissa, Stephenson, Tara, Van Rampelbergh, Rian, Banerjee, Arnob, Goldberg, Jenna D., Kobos, Rachel, Krishnan, Amrita, Usmani, Saad Z.
Published in The New England journal of medicine (11.08.2022)
Published in The New England journal of medicine (11.08.2022)
Get full text
Journal Article
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
Usmani, Saad Z, Garfall, Alfred L, van de Donk, Niels W C J, Nahi, Hareth, San-Miguel, Jesus F, Oriol, Albert, Rosinol, Laura, Chari, Ajai, Bhutani, Manisha, Karlin, Lionel, Benboubker, Lotfi, Pei, Lixia, Verona, Raluca, Girgis, Suzette, Stephenson, Tara, Elsayed, Yusri, Infante, Jeffrey, Goldberg, Jenna D, Banerjee, Arnob, Mateos, María-Victoria, Krishnan, Amrita
Published in The Lancet (British edition) (21.08.2021)
Published in The Lancet (British edition) (21.08.2021)
Get full text
Journal Article
Model-Based Exploration of the Impact of Prophylactic Tocilizumab on IL-6 Dynamics in Multiple Myeloma Patients Receiving Teclistamab Treatment
Zhou, Jia, Vishwamitra, Deeksha, Guo, Yue, Verona, Raluca, Perales Puchalt, Alfredo, Stephenson, Tara, Hodin, Caroline, Banerjee, Arnob, Chastain, Katherine, Haddish-Berhane, Nahor, Wang, Weirong
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Longer-term follow-up of patients (pts) receiving prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) in the phase 1/2 MajesTEC-1 study of teclistamab in relapsed/refractory multiple myeloma (RRMM)
van de Donk, Niels W.C.J., Garfall, Alfred L., Benboubker, Lotfi, Uttervall, Katarina, Groen, Kaz, Rosiñol, Laura, Matous, Jeffrey V, Vishwamitra, Deeksha, Hodin, Caroline, Stephenson, Tara, Qi, Keqin, Zuppa, Athena, Chastain, Katherine, Mateos, Maria-Victoria
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Longitudinal Correlative Profiles of Responders, Nonresponders, and Those with Relapse on Treatment with Teclistamab in the Phase 1/2 MajesTEC-1 Study of Patients with Relapsed/Refractory Multiple Myeloma
Vishwamitra, Deeksha, Skerget, Sheri, Cortes, Diana, Perova, Tatiana, Lau, Onsay, Davis, Cuc, Guo, Yue, Miao, Xin, Stephenson, Tara, Hodin, Caroline, Uhlar, Clarissa, Trancucci, Danielle, Chastain, Katherine, Bahlis, Nizar J, Van De Donk, Niels W.C.J., Verona, Raluca
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma
Garfall, Alfred L., Nooka, Ajay K., van de Donk, Niels W.C.J., Moreau, Philippe, Bhutani, Manisha, Oriol, Albert, Martin, Thomas G., Rosiñol, Laura, Mateos, Maria-Victoria, Bahlis, Nizar J., Popat, Rakesh, Besemer, Britta, Martinez-Lopez, Joaquin, Krishnan, Amrita Y., Delforge, Michel, Huang, Lin, Vishwamitra, Deeksha, Stephenson, Tara, Chastain, Katherine, Sidana, Surbhi
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Durability of responses with biweekly dosing of teclistamab in patients with relapsed/refractory multiple myeloma achieving a clinical response in the majesTEC-1 study
Usmani, Saad Zafar, Karlin, Lionel, Benboubker, Lotfi, Nahi, Hareth, San-Miguel, Jesús, Trancucci, Danielle, Qi, Keqin, Stephenson, Tara, Perales-Puchalt, Alfredo, Chastain, Katherine, Chari, Ajai
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Get full text
Journal Article
Conference Proceeding
Long-term follow-up from MajesTEC-1 of teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
van de Donk, Niels W.C.J., Moreau, Philippe, Garfall, Alfred L., Bhutani, Manisha, Oriol, Albert, Nooka, Ajay K., Martin, Thomas G., Rosiñol, Laura, Mateos, Maria-Victoria, Bahlis, Nizar J., Popat, Rakesh, Besemer, Britta, Martinez-Lopez, Joaquin, Krishnan, Amrita Y., Delforge, Michel, Trancucci, Danielle, Verona, Raluca, Stephenson, Tara, Chastain, Katherine, Sidana, Surbhi
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) to inform the management of patients (pts) treated with teclistamab in MajesTEC-1
van de Donk, Niels W.C.J., Garfall, Alfred L., Benboubker, Lotfi, Uttervall, Katarina, Groen, Kaz, Rosiñol, Laura, Hodin, Caroline, Stephenson, Tara, Trancucci, Danielle, Perales-Puchalt, Alfredo, Kobos, Rachel, Banerjee, Arnob, Mateos, Maria-Victoria
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Get full text
Journal Article
Conference Proceeding
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study
Cortes-Selva, Diana, Perova, Tatiana, Skerget, Sheri, Vishwamitra, Deeksha, Stein, Sarah, Boominathan, Rengasamy, Lau, Onsay, Calara-Nielsen, Karl, Davis, Cuc, Patel, Jaymala, Banerjee, Arnob, Stephenson, Tara, Uhlar, Clarissa, Kobos, Rachel, Goldberg, Jenna, Pei, Lixia, Trancucci, Danielle, Girgis, Suzette, Wang Lin, Shun Xin, Wu, Liviawati S., Moreau, Philippe, Usmani, Saad Z., Bahlis, Nizar J., van de Donk, Niels W. C. J., Verona, Raluca I.
Published in Blood (08.08.2024)
Published in Blood (08.08.2024)
Get full text
Journal Article
POSTER: MM-162 Durability of Responses With Biweekly Dosing of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma Achieving a Clinical Response in the MajesTEC-1 Study
Usmani, Saad Z, Karlin, Lionel, Benboubker, Lotfi, Nahi, Hareth, San-Miguel, Jesús, Trancucci, Danielle, Qi, Keqin, Stephenson, Tara, Puchalt, Alfredo Perales, Chastain, Katherine, Chari, Ajai
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
MM-162 Durability of Responses With Biweekly Dosing of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma Achieving a Clinical Response in the MajesTEC-1 Study
Usmani, Saad Z, Karlin, Lionel, Benboubker, Lotfi, Nahi, Hareth, San-Miguel, Jesús, Trancucci, Danielle, Qi, Keqin, Stephenson, Tara, Puchalt, Alfredo Perales, Chastain, Katherine, Chari, Ajai
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Teclistamab and talquetamab modulate levels of soluble B-cell maturation antigen in patients with relapsed and/or refractory multiple myeloma
Girgis, Suzette, Wang Lin, Shun Xin, Pillarisetti, Kodandaram, Verona, Raluca, Vieyra, Diego, Casneuf, Tineke, Fink, Damien, Miao, Xin, Chen, Yang, Stephenson, Tara, Banerjee, Arnob, Hilder, Brandi, Russell, Jeffery Scott, Smit, Jennifer, Goldberg, Jenna D.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Teclistamab Population Pharmacokinetics and Exposure-Response Relationship Support 1.5 Mg/Kg Dose Regimen in Relapsed/Refractory Multiple Myeloma
Miao, Xin, Wu, Liviawati S., Wang Lin, Shun Xin, Xu, Yan, Chen, Yang, Iwaki, Yuki, Kobos, Rachel, Stephenson, Tara, Kemmerer, Kristy, Uhlar, Clarissa M., Banerjee, Arnob, Goldberg, Jenna D., Trancucci, Danielle, Verona, Raluca, Pei, Lixia, Su, Yaming, Ouellet, Daniele, Garfall, Alfred L., Krishnan, Amrita Y., Usmani, Saad, Girgis, Suzette, Zhou, Honghui
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article